Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
November 4, 2024
Preclinical Evaluation of MK-8189: A Novel Phosphodiesterase 10A Inhibitor for the Treatment of Schizophrenia
Sean Smith, Dawn Toolan, Monika Kandebo, et al.
Neurobiology of Aging
|
January 22, 2018
Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease
Paige E Cramer, Renee C Gentzel, Keith Q Tanis, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
December 14, 2020
A Novel Biomarker of Neuronal Glutamate Metabolism in Nonhuman Primates Using Localized <sup>1</sup>H-Magnetic Resonance Spectroscopy: Development and Effects of BNC375, an α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator
Corin O Miller, Liza T Gantert, Stephen F Previs, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
Preclinical evaluation of MK-8189: A novel phosphodiesterase 10A inhibitor for the treatment of schizophrenia
Sean M Smith, Dawn Toolan, Monika Kandebo, et al.
Psychopharmacology
|
September 21, 2013
The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey
Donnie Eddins, Terence G Hamill, Vanita Puri, et al.
Plos One
|
April 7, 2018
Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
Xiaohai Wang, Karen Smith, Michelle Pearson, et al.
Journal of Neurochemistry
|
April 27, 2017
The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine
Lihang Yao, Andres D Ramirez, Anthony J Roecker, et al.
Neuropharmacology
|
November 30, 2010
Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration
Sophie Parmentier-Batteur, Julie A O'Brien, Scott Doran, et al.
Psychopharmacology
|
July 25, 2012
The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque
Jason M Uslaner, Donnie Eddins, Vanita Puri, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 2018
Preclinical to Human Translational Pharmacology of the Novel M<sub>1</sub> Positive Allosteric Modulator MK-7622
Jason M Uslaner, Scott D Kuduk, Marion Wittmann, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
The Journal of Pharmacology and Experimental Therapeutics
|
November 4, 2024
Preclinical Evaluation of MK-8189: A Novel Phosphodiesterase 10A Inhibitor for the Treatment of Schizophrenia
Sean Smith, Dawn Toolan, Monika Kandebo, et al.
Neurobiology of Aging
|
January 22, 2018
Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease
Paige E Cramer, Renee C Gentzel, Keith Q Tanis, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
December 14, 2020
A Novel Biomarker of Neuronal Glutamate Metabolism in Nonhuman Primates Using Localized <sup>1</sup>H-Magnetic Resonance Spectroscopy: Development and Effects of BNC375, an α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator
Corin O Miller, Liza T Gantert, Stephen F Previs, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
Preclinical evaluation of MK-8189: A novel phosphodiesterase 10A inhibitor for the treatment of schizophrenia
Sean M Smith, Dawn Toolan, Monika Kandebo, et al.
Psychopharmacology
|
September 21, 2013
The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey
Donnie Eddins, Terence G Hamill, Vanita Puri, et al.
Plos One
|
April 7, 2018
Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
Xiaohai Wang, Karen Smith, Michelle Pearson, et al.
Journal of Neurochemistry
|
April 27, 2017
The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine
Lihang Yao, Andres D Ramirez, Anthony J Roecker, et al.
Neuropharmacology
|
November 30, 2010
Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration
Sophie Parmentier-Batteur, Julie A O'Brien, Scott Doran, et al.
Psychopharmacology
|
July 25, 2012
The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque
Jason M Uslaner, Donnie Eddins, Vanita Puri, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 2018
Preclinical to Human Translational Pharmacology of the Novel M<sub>1</sub> Positive Allosteric Modulator MK-7622
Jason M Uslaner, Scott D Kuduk, Marion Wittmann, et al.
Page
of 8